{Reference Type}: Journal Article
{Title}: Advances in omics-based biomarker discovery for biliary tract malignancy Diagnosis:A narrative review.
{Author}: Xu T;Lyu L;Zheng J;Li L;
{Journal}: Mol Cell Probes
{Volume}: 76
{Issue}: 0
{Year}: 2024 Aug 6
{Factor}: 3.285
{DOI}: 10.1016/j.mcp.2024.101970
{Abstract}: Biliary tract neoplasms, which originate from the intrahepatic or extrahepatic biliary epithelium, are relatively rare but diagnostically challenging types of tumours, and their morbidity and mortality have increased in recent years. Due to ineffective early diagnostic methods, once detected, patients are in an advanced stage with a poor prognosis and few treatment options. With the development of omics technologies, the associations between microorganisms, bile acid and salts, noncoding RNAs and biliary tract malignancies have been gradually revealed, providing new methods for the discovery of diagnostic biomarkers. Here, we review the research advances in microbiomics, transcriptomics, metabolomics, and proteomics in the discovery of diagnostic biomarkers for biliary tract malignancies.